Do peptides really compare to HGH? A skeptical look at the claims

What's this video probably claiming?

Based on the caption, hashtags, and creator context, @catabolyc is likely walking viewers through a comparison of growth hormone secretagogues, specifically peptides like CJC-1295, ipamorelin, MK-677, or GHRP-6, versus actual exogenous human growth hormone (HGH). The framing, "none compare to actual HGH but they can be useful in specific settings," suggests the creator is positioning these peptides as a second-tier option. This is a common narrative in bodybuilding communities that tends to be more nuanced than most peptide hype, but it still likely oversimplifies the pharmacology. The hashtags #roids and #looksmax signal an audience oriented toward performance enhancement, not clinical therapy. That context matters a lot when evaluating what "useful" means, because useful for a bodybuilder chasing IGF-1 spikes is a very different claim than useful for someone with documented growth hormone deficiency.

What does the science actually show?

The creator's core premise, that exogenous HGH produces stronger effects than peptide secretagogues, is broadly supported by the existing literature, but the details are where things get complicated. Exogenous recombinant HGH (somatropin) raises IGF-1 levels in a dose-dependent, predictable way. Peptide secretagogues like CJC-1295 combined with ipamorelin stimulate endogenous GH pulses, but the ceiling is physiologically constrained by your own pituitary capacity. A 2006 study by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism showed CJC-1295 at doses of 1-2 mg increased mean GH concentrations by 2-10 fold and IGF-1 by 1.3-1.5 fold over baseline in healthy adults, effects that are real but fall short of supraphysiologic HGH dosing. MK-677 (ibutamoren), an oral ghrelin mimetic, showed sustained IGF-1 increases of roughly 60% over baseline in a 2-year trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism), though it also raised fasting glucose and insulin, a tradeoff frequently omitted in social media discussions.

Where does the social media noise diverge from clinical reality?

The biggest gap between gym-community peptide talk and clinical reality is the assumption that stimulating more GH is straightforwardly beneficial for body composition. That assumption is messier than it looks. First, most secretagogue studies showing body composition changes used clinical populations with documented GH deficiency, not healthy young men already in the normal range. Second, the pulsatile GH release that secretagogues produce is pharmacologically different from a continuous elevation, and whether that matters for muscle protein synthesis in healthy adults is genuinely unclear. Third, the compounded peptides circulating in the market are not equivalent to the pharmaceutical-grade compounds tested in clinical trials. Purity, sterility, and concentration vary significantly across compounding pharmacies. Claiming you can replicate a Teichman 2006 outcome with a vial ordered online is a stretch the data does not support. The creator's framing is more honest than most in this space, but the "useful in specific settings" claim still deserves scrutiny about which settings and which people.

What should you actually know?

If you are considering any growth hormone secretagogue, the evidence base is thinner than the bodybuilding internet suggests. CJC-1295 and ipamorelin have a handful of small trials, mostly industry-funded, in populations that do not look like recreational gym users. MK-677 has somewhat more data but carries real metabolic risks including increased fasting insulin and potential worsening of insulin sensitivity, which Nass et al. documented over a two-year follow-up. None of these compounds are FDA-approved for body composition or anti-aging purposes. They exist in a regulatory gray zone, which means dosing, quality control, and long-term safety monitoring are your problem, not your pharmacy's. The creator's broader point, that these compounds sit below exogenous HGH in terms of raw effect magnitude, is reasonable. But "less powerful than an illegal drug" is not the same as "safe and appropriate for you." Any legitimate use of these compounds should involve baseline labs, physician oversight, and honest conversation about what the evidence actually shows.